Product Name |
Recombinant Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Protein |
Product Overview |
This recombinant human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) protein includes amino acids 8-156aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in PBSprior to lyophilization. |
Target Uniprot Id |
Q8N726 |
Recommended Name |
Tumor suppressor ARF |
Gene Name |
CDKN2A |
Synonyms |
P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cycli |
Species |
Human |
Predicted Molecular Mass |
20 kDa |
Expression System |
E.coli |
Expression Range |
8-156aa |
Tag |
N-6His |
Purity |
>90% |
Formulation |
Lyophilized |
Buffer |
PBS |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |